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ABSTRACT
Analysis of Gene Transcription Changes Following Chlamydia pneumoniae Infection
ofTHPl Monocytes may have relevance to Alzheimer's Disease
Desire Guthier
M.S. in Biomedical Sciences, 2019
Dr. Brian J. Balin Ph.D., Thesis Advisor

There is increasing evidence that neuroinflammation caused by infectious agents
is an important etiologic factor in neurodegenerative diseases including Alzheimer's
disease (AD). One infectious agent that has been associated with AD is Chlamydia
pneumoniae (Cpn). Cpn DNA can be detected within peripherally circulating
mononuclear cells and there is evidence that infected mononuclear cells could be
involved in chronic infection and contribute to inflammation at numerous anatomical
sites, including the brain. Understanding Cpn genetic changes progressing from an acute
to a chronic infection within monocytes may help to further elucidate. the role of Cpn
infected monocytes with regard to the neurodegeneration observed within AD. In this
study, monocytes were infected in vitro with Cpn (either AR39 or CWL029) for 24, 48,
72, 96, or 120 hours. Subsequently, we investigated transcriptional gene changes of 7
Cpn genes using RT- PCR. We found a significant drop in gene expression at later time
points in 3 of the genes. Our results demonstrate differences in gene expression from
acute to chronic infection that perhaps indicate a trend towards persistence. However, our
data does not unequivocally support that these gene changes are representative of the
progression from acute to persistent infection. Future studies are required to resolve these
differences and determine important gene changes that indicate persistent Cpn infection
within monocytes.
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INTRODUCTION

Alzheimer's Disease (AD) is a neurodegenerative disorder that currently affects
an estimated 5.8 million Americans (1). As the population of the U.S., age 65 and older,
continues to increase, this number is expected to escalate to 14 million by 2050 (1). In

2019, Americans will pay an estimated $290 billion on direct health care cost to care for
those with AD and dementia (1). With statistics as stark as these, continued medical
research into the etiology and pathogenesis of this disease is mandated.
Symptomatology of AD occurs on a progressive timeline; the beginning stage
often presents as an insidious onset of short-term memory loss, altered mood, behavior,
and impaired higher cognitive function, while later stages of the disease progress to
incapacitating memory loss, disorientation, and eventually death (2). There are two
known forms of Alzheimer disease: the early onset familial form (FAD) which accounts
for -5% of all AD cases and the late onset (LOAD) that accounts for the other -95% of
AD cases (3) . FAD is a genetic disease characterized by various mutations in one or
more of the following genes, the amyloid precursor protein gene (APP), presenilin 1
gene, and the presenilin 2 gene (3). These mutations result in increased~- amyloid (A~)
production and deposition extracellularly. A second defining neuropathological entity,
the neurofibrillary tangles (NFTs), accumulate intracellularly within damaged neurons.
Together, the two pathologies are the hallmark of AD. Unlike Familial AD, LOAD is not
a result of genetic mutation. Environmental and genetic risk factors for LOAD have been
identified (3), however, very little is known about the specific etiology and pathogenesis
of this fatal disease.
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There is controversy around the initiating factors of AD. One of the more widely
accepted theories, coined the amyloid cascade hypothesis, involves the improper
processing and cleavage of APP leading to AP production and deposition extracellularly
(4). In both FAD and LOAD, Neurofibrillary tangles (NFTs) can accumulate
intracellular!y within damaged neurons (2). NFTs are made of the misfolded and
hyperphosphorylated protein tau, a microtubule associated protein functioning normally
as a structural and transport protein within the nerve cell. In the diseased state, the cell
structure collapses and tau can no longer assist with the microtubule transportation of
nutrients and neurotransmitters (2).
For the past two decades, AP plaques have been thought to initiate the
pathological process of AD and be a significant contributor to neurotoxicity (5).
However, this theory has been disputed for a number of reasons. For one, concentrations
of plaques in the AD brain are in the picomolar range but given the amount of
neurotoxicity displayed, the plaque concentrations would be expected to be a million
times more concentrated in the micromolar range (6). Secondly, studies have shown
through histochemical and immunocytochemical analyses, that numerous patients with
AP amyloid deposition, examined postmortem, did not have symptoms of AD (7). This
suggests that AP deposition may not necessarily be responsible for cognitive decline (7).
Further, AP peptides may have neuroprotective effects by functioning as antimicrobial
anionic defensive peptides (8). One more reason for disputing the amyloid hypothesis is
clinical trial failures (9). Disease modifying drugs developed thus far have included drugs
to reduce AP production, prevent AP aggregation, and drugs to promote AP clearance
which have all demonstrated no efficacy and have failed phase III clinical trails (9).
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Therefore, many questions remain unanswered about the true etiology and pathogenesis
of LOAD, and as such, consideration of other evidence is warranted.
Inflammation in the brain in LOAD is a contributing factor to the neuropathology
observed in AD. Activated microglia that respond to

A~

deposition and/or other insults

may initiate and propagate an inflanunatory response (6). Without complete clearance of
the initiating stimuli, the cascade of neuroinflanunation and neuropathology may be
chronic (6). To date, clinical trials using NSAIDS as a method for treatment have proved
ultimately unsuccessful (10). There has been some evidence to suggest that continued use
ofNSAIDs can delay onset of symptoms, but once cognitive dysfunction becomes
apparent NSAIDs seem to have no effect (10-12).
Interestingly, another stimulus for neuroinflanunation in AD may be infection (3,
13, 14). An infectious etiology for many chronic diseases, including AD, is not a foreign
concept and has long been debated. Although infectious etiology of LOAD is not the
standard dogma in the AD scientific conununity, there are many researchers around the
world looking at infections as possible causative agents of LOAD. Prime examples of
infectious agents being studied as potential pathologic causes of LOAD are Spirochetes
(15), Herpes Simplex Virus 1(16, 17) and Chlamydia pneumoniae (Cpn) (3, 13, 14). Cpn
is a very interesting potential etiologic agent of AD, and is the focus of this research
study.
There is strong evidence to suggest a potential causal relationship between Cpn
and LOAD. The first study correlating Cpn to AD was published in 1998 (18). The study
looked at brain tissue samples from post- mortem LOAD patients as well as control brain
tissue samples and used PCR with probes specific to Cpn DNA ( 18). Interestingly, 90%
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of the postmortem brain tissues from AD patients were infected with Cpn in areas of the
brain that usually exhibit AD pathology (18). This was compared to the control postmortem brain tissue samples where only 5% of the brain tissue samples were determined
to be infected with Cpn (18). The presence of Cpn in the AD brain the study used
immunohistochemistry and electron microscopy techniques and results correlated with
their initial PCR findings (18). The 1998 study also observed an interesting connection
between ApoE e4 allele and Cpn, a noted risk factor for AD. Eleven out of the 19 cases
that were infected with Cpn in the LOAD brain also had at least one ApoE E4 allele (18).
Additional evidence was obtained when non-transgenic BALB/c mice were intranasally
infected with Cpn;

A~

deposits similar to plaques found in AD brains were found within

tbe infected brains of the mice in areas typically affected in AD (19, 20}.
Cpn is an obligate intracellular bacterium and is a pervasive respiratory pathogen

(21 ). The acute infection witb Cpn has a distinct developmental cycle that alternates
between two morphological forms; the metabolically inactive and infectious form termed
the elementary body (EB) and the metabolically active form responsible for repeated
binary fission termed the reticulate body (RB) (21). After endocytic host cell entry, the
EB converts to its metabolically active RB form and a specialized vacuole or inclusion
body encapsulates the dividing bacteria (22). The RB are able to efficiently acquire
nutrients from the host for fast replication and other metabolic activities within the host
cell but are also not infectious and less stable than EBs at this point in their life cycle
(23). The infection modifies host cell lysosomal pathways preventing lysosomal fusion
with the vacuole, and the organism continues to multiply prior to conversion back to EBs
for release from the cell and dissemination.
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Cpn is airborne and is transmitted through respiratory droplets from person to

person (24). Cpn is an etiologic agent for community acquired pneumonia and bronchitis
(24) but has also been shown to disseminate throughout the body and may lead to
exacerbation of atherosclerosis and possible involvement in AD etiology (18, 25).
Furthermore, Cpn infection has also been associated with asthma (26), lung cancer (27),
arthritis (28), chronic obstructive pulmonary disease (29), and diabetes (30). Potential
modes of Cpn dissemination throughout the body have not been completely elucidated
but there is strong evidence to suggest that the organism can move from the respiratory
tract by a number of mechanisms. First Cpn can infect monocytes in the lung tissues and
can travel systemically to many regions of the body (31). Of particular interest relating to
AD, Cpn may enter the brain through the blood-brain barrier following infection of
monocytes. Research has shown that Cpn infected monocytes can mitigate transendothelial entry through human brain microvascular endothelial cells (HBMECs) by upregulation ofVCAM-1 and ICAM-1 on HBMECs and increasing LFA-1, VLA-4, and
MAC-1 on infected monocytes (31 ). This is an important discovery providing evidence
on how Cpn could invade the brain to eventually promote inflammation characteristic of
AD (31).
Another possible route for Cpn entry into the CNS is through the olfactory
system. Since Cpn is a respiratory pathogen, it has ready access to olfactory
neuroepithelium of the nasal olfactory system. Upon infection of these cells, the
organisms could migrate to the olfactory bulbs and then to deeper areas of the brain such
as the entorhinal cortex and hippocampus (32). Interestingly, an impaired sense of smell
and olfactory dysfunction has been noted as an early dysfunction in AD (33).
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Cpn has been reported to enter a chronic infectious state leading to persistence
characterized by a long-term relationship between bacteria and infected host cells,
including monocytes/macrophages (22). Cpn persistent infection is characterized by
visualization through electron microscopy of enlarged, morphologically aberrant RBs that
do not mature into infectious EBs (34, 35). Persistent infection may cause
pathophysiology in chlamydia! related diseases including AD (14, 36). For this reason, it
is important to investigate causes of persistence and changes in Cpn gene expression
during persistence to further understand host interaction. Cpn entering the persistent state
as a response to stress is the current paradigm (36). Studies have been performed in
which Cpn was driven into a persistent infection following exposure to antibiotics,
interferon-y (IFN-y), and iron starvation(22, 37, 38) Intriguingly, current research
suggests that Cpn persistence also may be a mechanism by which evasion of the host
immune response through alternative metabolic pathways may occur (36).
As previously stated, although a specific etiology of LOAD pathogenesis has not
been defined, evidence surrounding inflammation as a central contributing factor of
LOAD pathology has been strongly suggested (39-42). In this regard, Cpn's ability to
maintain a chronic infection within monocytes has been shown to induce an
inflammatory cascade (43). Cpn infection ofmonocytes in vitro has been shown to result
in significant cytokine production including that ofIL-1~, IL-6, and IL-8 (43). Thus if,

Cpn infected monocytes cross the blood brain barrier, they have the potential to produce
a significant inflammatory response that could lead to pathology seen in AD. How Cpn
infection becomes chronic and/or persistent in monocytes to modulate the host immune
response has not been fully elucidated. Genome wide Cpn analyses have been performed
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within epithelial cells during an acute and induced persistent state to further understand
Cpn and host interactions (22, 35, 44). Very few studies have looked at Cpn gene
transcription within infected monocytes/ macrophages (34, 45).
Although Cpn Gene expression within monocytes is not well understood, it is
crucial to the understanding of disease pathogenesis in which chronic or persistent
infection is evident. Given the limited gene transcription analysis that has been performed
within monocytes (22, 35, 44, 45), we examined the following Cpn genes; euo, 129, abcX,
ttif, hctA, lctH, and J 6S (see table 1) within two different Cpn respiratory strains (AR39
and CWL029) to better understand Cpn gene expression following infection of human
THPl monocytes over a time course of24-120 hours post infection (hpi).
Two corurnon Cpn respiratory strains were chosen because it has been discovered
that there are genetic differences between AR39 and CWL029, specifically 16111165
proteins are not identical (46). Most importantly, there is a plasmid that is present in
AR39 but not in CWL029 (46). For this reason, we wanted to determine if there is a
difference in gene expression between AR39 and CWL029 following infection of
monocytes. In addition, Cpn strains AR39 and CWL029 strains have been shown to be
most closely related to the Cpn strains found in the AD brain and have also been shown
to cause A~ deposits similar to plaques in AD brains in mice (20).
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Table 1 Cpn genes examined and life cycle expression of those genes. In our study we
examined the Cpn genes listed in the above table. These genes were chosen based on
previous research showing evidence that these particular genes were expressed at variable
time points in the Cpn life cycle (22). Gene expression profiles for Cpn have been
previously defined in clusters. These clusters are defined by genes that are active at the
same time in the life cycle: acute (24-48 hpi) and chronic (72-120 hpi) (22). We adopted
this model in our study in order to further classify and choose genes of interest. In
addition, each of these genes has shown to change its expression in a persistent state
within an epithelial cell line (22).
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1.1 Hypothesis

There will be gene transcriptional changes of Cpn following infection of human THPl
monocytes over a 120-hour time course that will reflect the evolution of an acute
infection to that of a chronic infection independent of the Cpn strain (AR39 and
CWL029) used for the infection.
1.2 Specific Aims

1. To analyze the percent of Cpn infected THPl after 24, 48, 72, 96, and 120 hours
post infection (hpi) with AR39 and CWL029 strains using immunofluorescent
labeling techniques.
2. To evaluate changes of gene expression between acute (24-48 hpi) and chronic
(72-120 hpi) stages ofCpn infection ofTHPl monocytes in two strains ofCpn
infection strain (AR39 and CWL029).
3. To determine ifthere is a difference in gene expression between AR39 and
CWL029 infection strains over 24-120 hours post infection.
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METHODS

2.1 THPl Human Monocytes
THP 1 monocytes were grown and maintained at lxl 06 cells/ml in RPMI growth
media (GM) supplemented with heat activated 10% Fetal Bovine serum in an incubator at
37

·c and 5% C02.

2.2 Infection with Cpn
THPl cells were centrifuged, washed with Hank's Balanced Salt Solution
(HBSS), and then re-suspended at a concentration of lxl0 6 cells/ mL in lmL of GM. One
of the two strains of human respiratory Cpn, AR39 or CWL029, were used to infect
THPl cells at Multiplicity oflnfection (MOI) of 1. Cells were incubated at 37"C and 5%
C02 for one hour in a T25 flask. GM was then added to the infected cells to bring the
total volume of the flask up to lOmL. Cells were then incubated at 37"C and 5% C02 and
infected THP 1 monocytes were extracted at 5 different time points: 24, 48, 72, 96 and
120 hours. Control experiments for all infected time points were performed with 1x106
uninfected cells suspended in 10 mL of GM.
At the time of extraction for both infected samples and controls, T25 flasks were
removed from the incubator and their contents were transferred into 25 mL tubes. The 25

mL tubes were centrifuged at 500 x g for 5 min. Supernatants were removed and pellets
were washed with HBSS. Cell concentration was then determined using a hemocytometer
and cell pellets consisting of lxl 06 cells were frozen at -60 "C until RNA extraction was
performed for RT-PCR.

II

2.3 RNA Isolation
RNA was purified according to the manufacturer's instructions using a RNeasy
isolation kit (Qiagen RNeasy). Frozen pellets were thawed and centrifuged for 5 min at
300 x g. Pellets contained lxl 06 cells for each sample. RLT (350 µI) was added to each
sample to disrupt cells. This entire mixture was then pipetted into a QIAshredder placed
in a 2ml collection tube. Sample was then centrifuged for 2 min at 20,000 x g to lyse
cells. The QIAshredder was discarded and flow through in the collection tube was
saved. 70% ethanol (350 µI) was added to the sample and mixed well. The entire volume
was then transferred into a RNeasy spin column in 2 ml collection tube and centrifuged
for l 5s at 8000 x g. The flow through and collection tube were discarded and the RN easy
spin column was placed above a new collection tube. Buffer RWI (350 µl) was added to
the RNeasy spin column with collection tube and centrifuged for 15s at 8000 x g to wash
the spin column membrane. Flow through was discarded and the RNeasy spin column
was transferred into a new collection tube. DNase stock solution I (10 µl) was added to
Buffer RDD (70 µl) and mixed thoroughly. DNase I incubation mix (80 µl) was added to
RNeasy spin column membrane and the mixture was allowed to sit for 15 min to digest
DNA. Buffer RWl (350 µl) was added to the RNeasy spin column with collection tube
and centrifuged for 15 sec at 8000 x g. Buffer RPE (500 µI) was added to the RNeasy
spin column and centrifuged for 2 min at 8000 x g in order to wash the spin column
membrane and dry any residual ethanol. The RNeasy spin column was then placed in a
new collection tube and spun for 1 min at 20,000 x g to dispose of any carry over Buffer
RPE. Flow through and collection tube were discarded. The RN easy spin column was
placed over a \ .5 ml collection tube. RNase free water (30 µI) was added to the RNeasy
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spin column and centrifuged for I min at 8000 x g. This step was then repeated for a total
of 60 µl of eluted RNA in RNase free water. Samples were frozen and stored at -60 "C
until RNA was used for RT-PCR.
After RNA isolation was perfo1med, overall RNA concentration was determined
from its optical density at 260 nm by using UV Spectrophotometry. Other measurements
recorded included purity values: A,,JA,,. and A,,J A,•.

2.4 First Strand Synthesis
Reverse transcription reaction was performed using RETROscript Kit (Applied
Biosystems) following manufacturer's protocol. RNA (500 ng) was mixed with 2 µl of
Random Decamers; nuclease-free water was added to this mixture to total 12 µI. The
mixture was then centrifuged briefly and heated for 3 min at 85 "C in order to denature
RNA. Each sample was briefly centrifuged and placed on ice. Two µl of !Ox RT buffer, 4
µl of dNTP mix, and 1 µI ofRNase inhibitor was added to the denatured RNA sample.
Samples were mixed thoroughly, centrifuged briefly, and incubated for 1 hour at 55 "C.
Sample were then incubated for 10 min at 92 "C to inactivate the reverse transcriptase.
Samples were then frozen and stored at -80 "C until cDNA was used for RT-PCR.
2.5 Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)
qRT- PCR was used to determine the relative level of gene transcription for the
following genes: euo, 129, abcX, tuf, hctA, lctH, Human I BS rRNA and chlamydia! J6S.
qRT-PCR was run following manufacturer's protocol (Taqman Gene Expression AssayApplied Biosystems) on Cpn infected THP 1 monocytes and their uninfected controls for
cDNA and DNA at 24, 48, 72, 96 and 120 hrs. For DNA samples, 10 µI of Master Mix, I
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µl of Primer, 250 ng of DNA, and DNase free water to equal 20 µl was added to each
well of the 96- well plate. For cDNA samples 10 µl of Master Mix, 1 µl of Primer, 2 µl
of cDNA, and DNase free water to equal 20 µl was added to each well of the 96- well
plate. The qRT- PCR plate was run and analyzed using Applied Biosystems StepOne and
StepOne plus Real-Time PCR systems. Expression of Cpn genes was normalized using
human 18S rRNA as an endogenous control.
2.6 Immunofluoresceuce

Cpn labeling was visualized at 24, 48, 72, 96, and 120 hpi for both AR39 and
CWL029 strains of Cpn. Cells at lxl0 5 were suspended in 400µ1 ofHBSS and pipetted
into Shandon single Cytology Funnels (Fischer Scientific, Pittsburg, PA) with inse1ied
Superfrost Slides (Fischer Scientific). Cytology Funnels containing slides and sample
were centrifuged for 5 min at 500 rpm, medium acceleration, using a Shandon Cytospin
III Cytocentrifuge. Cells were fixed onto slides with BD Cytofix/ Cytoperm for 30 mins,
and washed with PBS at room temperature and immunolabeled with Cpn specific
antibody (FITC directly tagged antibody 61C75, ThermoFischer) at 37°C for one hr.
Slides were washed with filtered water and mounted with Flouro-gel II Mounting
medium with DAPI and coverslips. Slides were stored at 4°C without light until
visualization.
Samples were viewed using a Nikon Eclipse 80i microscope 40x Nikon Plan
Flour 40x/0.75 OFN25 DIC M/N2 objective. For each slide, 10 fields were captured
using Nikon DS- Ri 1 Camera and NIS- Elements Advanced Research Software version
3.0 (Nikon). For each field captured, total cell counts and Cpn-infected cell counts were
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documented. Criteria for positive cell count required visualization of tlnee or more
punctate bodies or 1 large inclusion. Percentage of infected cells were determined from
these counts at each time point. Experiments were performed in triplicate and counts
were averaged for statistical significance.
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RESULTS
3.1 Qualitative evaluation of Cpn infection using immunofluorescent microscopy

Cultures ofTHPl monocytes infected with Cpn strains CWL029 andAR39 for
24, 48, 72, 96, or 120 hrs were evaluated for percent infectivity using immunofluorescent
microscopy analysis. Figure I shows representative micrographs of AR39 infected THPl
monocytes at 24, 48, 72, 96, and 120 hours post-infection (hpi) and uninfected control
cells. The percent infected at 24, 48, 72, 96, and 120 hpi were 52.4 ± 1.0%, 47.0 ± 1.8%,
53.9 ± 4.0%, 46.6 ± 2.8, and 48.3 ± 4.1 %, respectively (see table 2). The uninfected
THP 1 monocytes showed 0% infectivity for all time points. Figure 2 shows
representative micrographs ofCWL029 infected THPl monocytes at 24, 48, 72, 96, and
120 hpi and uninfected control groups. The percentage of cells infected at 24, 48, 72, 96
and 120 hpi were 41.3% ± 1.7, 45.0% ± 4.5, 55.6% ± 4.7, 61.8% ± 4.7, and 62.7 ± 2.6%,
respectively (see table 3). The uninfected THPl monocytes showed 0% infectivity for all
time points.
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Figure 1. Immuuofluorescent labeling of AR39 Infected THPl Monocytes.
At all-time points, 24-120 hours uninfected cells were immunolabeled for Cpn and shown
to be negative for infection (representative micrograph, A). THP 1 Monocytes infected for
24, 48, 72, 96, and 120 hpi demonstrated Cpn (green) respectively (B-F). Cell nuclei in
all micrographs were labeled with DAPI (blue). Original magnification (400x).
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Figure 2. Immuuofluorescent labeling of CWL029 Infected THPl Monocytes. At all
time points, 24-120 hours uninfected cells were immunolabeled for Cpn and shown to be
negative for infection (representative micrograph, A). THPl Monocytes infected for 24,
48, 72, 96, and 120 hpi demonstrated Cpn (green) respectively (B-F). Cell nuclei in all
micrographs were labeled with DAPI (blue). Original magnification (400x).
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3.1.1 Determining percent infectivity using immunofluorescent labeling
Total# of
Total# of
Percent
Percent
Cells
Cells
Infected
Totals
Positive
Counted
Experiment I 60
113
53.1
52.4 ± 1.0
-24 bpi
Experiment 2 60
51.2
125
Experiment 3 54
102
52.9
Experiment I 56
45.2
124
48 hpi
47.0 ± 1.8
Experiment 2 62
127
48.8
Experiment 3 56
119
47.l
Experiment 1 55
105
52.4
53.9 ±4.0
72 hpi
Experiment 2 95
187
50.8
Experiment 3 122
58.4
209
43.3
Exoeriment 1 56
129
46.6 ±2.8
96 hpi
Experiment 2 84
48.3
174
Exoeriment 3 102
212
48.l
Experiment 1 49
96
51.0
120 hpi
48.3 ± 4.1
Exoeriment 2 89
177
50.3
Experiment 3 80
184
43.5
Table 2. Percent infectivity using immnnoflnorescent labeling of AR39 infected
THPl monocytes.
AR39

Biological
Replicates

At all-time points, 24-120 hours uninfected cells were immnnolabeled for Cpn and shown
to be negative for infection (cell counts not shown). THPl monocytes infected for 24-120
hpi were immunolabeled for Cpn. For each experiment, 10 fields were captured using
Nikon DS- Ril Camera and NIS- Elements Advanced Research Software version 3.0
(Nikon). Criteria for positive cell count required visualization of three or more punctate
bodies or 1 large inclusion.
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Number of Total cells
Percent
Percent
Cells
Counted
Infected
Totals
Positive
Experiment 1 50
124
40.3
41.3 ± 1.7
24 bpi
Experiment 2 56
40.3
139
Experiment 3 77
178
43.3
Experiment 1 59
121
48.8
45.0±4.5
48bpi
Experiment 2 97
210
46.2
Experiment 3 69
40.l
172
51.9
Experiment 1 83
160
55.6±4.7
72 bpi
Experiment 2 72
133
54.1
Experiment 3 98
161
60.9
Experiment 1 81
121
66.9
61.8 ± 4.7
96 bpi
Experiment 2 99
172
57.6
Experiment 3 178
292
61
Experiment 1 125
198
63.1
62.7 ± 2.6
120 bpi
Experiment 2 102
157
65
152
59.9
Experiment 3 91
Table 3. Percent infectivity using immunofluorescent labeling of CWL029 infected
THPl monocytes.
CWL029

Biological
Replicates

At all-time points, 24-120 hours uninfected cells were immunolabeled for Cpn and shown
to be negative for infection (cell counts not shown). THPl monocytes infected for 24-120
hpi were immunolabeled for Cpn. For each experiment, 10 fields were captured using
Nikon DS- Ril Camera and NIS- Elements Advanced Research Software version 3.0
(Nikon). Criteria for positive cell count required visualization of three or more punctate
bodies or 1 large inclusion.
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3.2 Cpn gene expression in human monocytes
We analyzed the transcription of 7 Cpn genes expressed by two different strains
(AR39 and CWL029) of Cpn in THP 1 monocytes. Cells were lysed and RNA was
extracted at 24, 48, 72, 96, and 120 bpi. Amplification of RNA from uninfected
monocytes was included as negative control. Forty-eight bpi was used as a reference time
point and JBS rRNA was used as a human housekeeping gene to normalize transcription
levels. RT reaction used cDNA, which was then used in RT-PCR. Relative quantities of
transcribed genes were obtained using qRT-PCR. All genes were evaluated in triplicate
per PCR plate and each gene was amplified on multiple PCR plates.
3.3 Normalization of Cpn gene transcription
Human JBS rRNA was used to normalize the Cpn transcription data. We initially
used chlamydia! J6S rRNA to normalize chlamydia! expression as numerous published
articles have used this gene as a housekeeper gene (22, 44, 50). However, during our
study we found that although J6S was stably expressed at each time point, there was
variability between the time points. Human JBS rRNA was the most stably expressed
gene we analyzed as the CT value for the expression was consistent regardless of time
point. This allowed us to compare Cpn expression levels to total gene expression iu the
cell making it the best candidate for a control in our experiments.
3.4 Cpn genes evaluated for transcriptional change
Expression of hctA of Cpn for strain AR39 had a 2.6 fold increase from 24 to 48
bpi. Gene expression continued to increase and peaked at 72 hours. A 3.5 fold decrease
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gene expression was observed from 72 to 96 hpi and remained low at 120 hpi. The same
gene in the CWL029 strain showed no difference (Figure 3).

Cpn lcrH transcription levels for strain AR39 were elevated at 72 hpi in
comparison to the other time points. A 2.4 fold increase from 48 hpi to 72 hpi is seen in
the AR39 Cpn strain. In contrast, CWL029 lcrH transcription levels decreased by 2.3 fold
from 48 hpi to 72 hpi. Both strains showed transcription levels decreasing at 96 hpi and
120 hpi. AR39 lcrH transcription levels decreased 6.5 fold from 48 hpi to 72 hpi.
CWL029 lcrH transcription levels decreased 1.8 fold from 48 hpi to 72 hpi (Figure 4).
Our data for Cpn AR39 tuf gene expression showed highest transcriptional levels
at 24 hpi by 3 .24 fold when compared to 48 hpi. Decreased levels of transcription by 3 .9
fold were observed at both 96 hpi and 120 hpi when compared to 48 hpi. Cpn CWL029
had much lower transcriptional levels at almost every time point, although, a similar
pattern to the AR39 strain was observed for 48-120 hpi (Figure 5).

Cpn AR39 I 6S rRNA expression interestingly shows transcription levels are 2.4
fold higher at 24 hpi and 1. 7 fold higher at 72 hpi when compared to 48 hpi.
Transcription levels then decrease by 1.16 fold at 96 hpi when compared to 48 hpi.
Transcription levels of I 6S rRNA for Cpn CWL029 were lower at 24, 72, 96 and 120 hpi
when compared to 48 hpi. Transcription levels were decreased by 3.2 fold and 5.4 fold at
96 hpi and 120 hpi, respectively when compared to 48 hpi (Figure 6).
Data for euo, /29 and abcX gene expression also was collected for both strains,
however standard deviations were too high to make any conclusions (raw data in
appendix).
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hctA gene expression for Cpn strain AR39
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Figure 3. Analysis of hctA gene expression of Cpn strain AR39 following infection of
THP 1 Human Monocytes. Cells were infected (MOI 1, n=12) with Cpn and relative
expression of hctA was quantified at 24, 48, 72, 96, and 120 hpi. 48 hpi was used as a
reference time point and I BS was used as an endogenous control. Data for the CWL029
strain was collected but not shown as there was not a change at any time point. n=number
of technical replicates from same sample. Error bars represent standard deviations.
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lcrH gene expression for Cpn strain AR39 vs CWL029
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Figure 4. Comparative analysis of lcrH gene expression following infection of THP 1
Human Monocytes with two different Cpn strains AR39 and CWL029. Cells were
infected separately (MOI 1) with Cpn (AR39, n=9 and CWL029, n=6) with Cpn and
relative expression of lcrH was quantified at 24, 48, 72, 96, and 120 hpi. 48 hpi was used
as a reference time point and 1 BS was used as an endogenous control. n= number of
technical replicates from same sample. Error bars represent standard deviations.
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tuf gene expression for Cpn strain AR39 vs CWL029
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Figure 5. Comparative analysis of tuf gene expression following infection of THP 1
Human Monocytes with two different Cpn strains AR39 and CWL029. Cells were
infected separately (MOI 1) with Cpn (AR39, n= 6 and CWL029, n=6) with Cpn and
relative expression of tuf was quantified at 24, 48, 72, 96, and 120 hpi. 48 hpi was used as
a reference time point and I SS was used as an endogenous control. n= number of
technical replicates from same sample. Error bars represent standard deviations.
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Figure 6. Comparative analysis of 16S gene expression following infection of THP 1
Human Monocytes with two different Cpn strains AR39 and CWL029. Cells were
infected separately (MOI 1) with Cpn (AR39, n=15 and CWL029, n=12) with Cpn and
relative expression of lcrH was quantified at 24, 48, 72, 96, and 120 hpi. 48 hpi was used
as a reference time point and 1BS was used as an endogenous control. n= number of
technical replicates from same sample. Error bars represent standard deviations.
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DISCUSSION
Previous studies have identified and analyzed transcriptional changes during the
developmental life cycle of Cpn during acute infection (22, 51, 52). Genome wide
transcriptional analyses have mostly been reported within epithelial cell lines (22, 35,
44 ), and while these studies have been monumentally important in understanding the life
cycle of Cpn, changes in gene expression within white blood cells is essential for a more
complete understanding of disease pathogenesis of AD. The monocyte is an important
link between acute and chronic infection with Cpn because of Cpns ability to maintain a
persistent state within the cell and cause the host cell to elicit a chronic inflammatory
response (43). In this regard, only a few studies have explored transcriptional gene
changes within monocytes (34, 45). In the current study, we have explored transcriptional
changes of Cpn within THP 1 monocytes in vitro to determine how gene changes are
regulated in a temporal pattern as the infection progresses.
Cpn replicates within a eukaryotic host cell in a unique developmental cycle
marked by EB and RB. The lifecycle of Cpn is marked by temporal genes that are
expressed during early, mid and late stages of the life cycle and in times of stress enter
into a persistent state (22). In the current study, we have evaluated the transcriptional
levels ofCpn genes at different time points of the Cpn lifecycle. For example, hctA is a
gene for Histone Hl like protein with homology to eukaryotic histone protein (54). HctA
has been proposed to be essential for differentiation from RB back to EB (55). During
acute infection, the gene is expressed in the late phase of the acute life cycle; previous
studies have shown increased transcriptional activity at 36 hpi during a 48 hour Cpn
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lifecycle (22). Expression of this histone like protein represses ftnther transcription and
translation of the chlamydia! genome (54, 56). In our study, following infection with the
AR39 strain of Cpn, the relative quantity of hctA more than doubled from 24 to 48 hours
and gene expression peaked at 72 hpi. These results are consistent with previous studies
showing increased expression in late phase of the life cycle. Unexpectedly, we found that
at 96 hpi and 120 hpi there was a significant drop in gene expression of hctA. Decreased
expression of hctA could possibly represent a trend towards persistence in monocytes.
However, previous studies have demonstrated conflicting data for expression of hctA
during persistence. One study demonstrated that depletion of iron lead to persistence and
hctA gene expression was unaltered during this state (22). In contrast, two studies

demonstrated that during penicillin induced persistence, down regulation of hctA
expression occurred (44, 57). Further, IFN-y models of persistence have shown both up
regulation of hctA (44) as well as down regulation of hctA (36). Variations in expression
of this gene could possibly be explained by the different conditions promoting persistence
in these models, however this correlation remains to be clarified.
Cpn gene analysis demonstrated that at 96 hpi and 120 hpi, the tuf gene was

downregulated significantly when compared to earlier time points. Tuf is a gene that
transcribes for an elongation factor that is highly conserved among eubacteria (58). Tuf
has been shown to be expressed during mid and late cycle with complex regulation (48).
Interestingly, this gene has also been used in previous studies as a housekeeping gene
following infection of epithelial cells (22). In our study we saw a drop-in gene expression
over time. Down regulation of tu[ at later time points could indicate a decrease in
translational activity and potentially indicate a trend toward Cpn persistence within
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monocytes. Confirmation of this persistence could be obtained upon visualizing
persistent aberrant bodies with ultrastructural analysis, which unfortunately was outside
the scope of the current study. Also, it would be interesting to see if similar results would
be obtained upon inducing persistence with methods such as exposure to IFN-y or iron
depletion.
Surprisingly, we found differences in gene expression between Cpn strains AR39
and CWL029. When evaluating AR39 at 72 hpi, lcrHhad increased expression from 48
hpi. When evaluating CWL029 there was a decrease in gene expression from 48 hpi.

LcrH is a gene that expresses a chaperone protein within the Cpn Type III secretion
system (T3SS), an important virulence factor that allows interaction between bacterium
and host. Bacteria use T3SS to inject proteins into the host cell cytosol changing the
environment in favor of bacterial survival (59). This could suggest that there may be
strain differences in expression of the T3SS. Since the T3SS changes the environment of
the host cytosol, differences in gene expression could potentially alter the expression of
multiple proteins.
Interestingly, with both the CWL029 and AR39 Cpn strains there was down
regulation in the lcrH gene expression at 96, and 120 hpi. These findings are consistent
with previous studies, which have shown decrease in lcrH gene expression during
persistent infections. IFN-y mediated persistence as well as iron depletion mediated
persistence has demonstrated down regulation of gene expression (22, 44, 60). Although
we are not able to specifically detennine persistence in our study, decreased transcription
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of lcrH during later timer points is interesting as it is consistent with downregulation of
gene transcription in iron depletion of Cpn which leads to persistence (22).
One interesting finding that we discovered is that Cpn l 6S was not the best
housekeeping gene for normalization, although, several previous studies normalized Cpn
gene expression to Cpn J6S (22, 44, 50). However, another study found similar results to
ours in that l 6S rRNA produced higher standard deviations compared to other
housekeeping genes (22). Subsequently, we found that THPl eukaryotic I BS was the
most stably expressed housekeeping gene in our study. This raises an important question
on choosing the best gene candidates for PCR normalization in any given experimental
design, and whether or not J6S should be used routinely as a housekeeping gene.
Cpn immunofluorescent data for the AR39 strain showed approximately 46-53%

percent infectivity at 24-120 hpi. Cpn immunofluorescent data for the CWL029 strain
showed approximately 41-62% percent infectivity at 24-120 hpi. We infected THPl
monocytes at an MOI= 1. However, multiple infectious units were present within THPl
monocytes and no infectious units were present in other cells. We believe that the same
number of infectious units were present in our experiment but did not infect the cells in a
1:1 ratio. Overall the infectivity of the THPl monocytes stayed relatively uniform from
24-120 hpi for both Cpn strain AR39 and CWL029. Our infection was maintained at the
same percent infectivity throughout 24 hpi-120 hpi and there was overall decrease in
gene transcription of the Cpn genes evalutated. This could potentially indicate a trend
toward a persistent infection since the infection is being maintained through 120 hpi at
around the same percent infectivity as the early time points and transcriptional levels are
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decreasing. However, it is nnclear weather or not the infection we are visualizing at the
chronic time points (after 48 hpi) could also represent a recycling of an acute infection.
These results would need to be confirmed with visualization on electron microscopy of

Cpn abberant bodies.
Some potential limitations to our study should be noted. There was only one
biological replicate used for each strain of Cpn. All other replicates were technical
replicates. Although there was a sample size of 6 or more per gene per time point studied,
in order to increase the statistical significance, the study should be replicated with
biological experimental replicates. In addition, we did not induce persistence with a
model such as exposing the bacteria to IFN-y. Having this data in comparison to the acute
infection to compare and contrast would strengthen our findings. In addition, in future
studies it would be important to visualize the organism within monocytes with electron
microscopy and compare this to the genetic data. This information would help us
determine a trend toward persistence, if we were able to visualize aberrant bodies.
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4.1 Conclusions
In conclusion, our study helps contribute to the overall understanding of how Cpn
interacts with its host. We still have a lot to learn about its interplay and only few studies
have evaluated Cpn gene expression within a monocyte cell line (34, 45), a crucial
component to the development of Cpn persistent infection and pathogenesis of AD. The
purpose of this study was to investigate transcriptional gene changes of Cpn following
infection of human THP I monocytes over a 120-hour time course to evaluate potential
evolution of an acute infection to that of a chronic infection. Our research demonstrates
certain gene changes that are suggestive of progression towards chronic and perhaps
persistent infection. In order to validate these findings, visualization of enlarged,
morphologically aberrant Cpn bodies through ultrastructural analysis is needed. In
addition, we would need more replication experiments to strengthen this study.
Previous studies have demonstrated that Cpn can establish a persistent infection
within monocytes and lead to chronic inflammation (43). It has been proposed that
monocytes can travel to distant anatomical sites, cross the blood brain barrier and
produce neuroinflammation. This neuroinflammation leads to the neurodegeneration seen
in LOAD (42). Therefore, an understanding of the evolution of acute to persistent Cpn
infection within monocytes is crucial to our understanding of disease pathogenesis of
LOAD.
Cpn gene expression within monocytes is still not well understood. Although
genome wide transcriptional analyses have been studied within epithelial cell lines,
monocytes are an important part of disease pathogenesis. Our study aids in this
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understanding, however there is much to still be elucidated within this field. Continued
research evaluating Cpn gene expression following infection of monocytes is crucial to
understanding the evolution of acute to persistent infection. Genetic profiling of Cpn will
help us better identify transcriptional patterns that are consistent with persistent Cpn
infections. In addition, a better understanding of gene expression and regulation could
potentially lead to treatments that could aid in eradicating persistent infections prior to
them leading to disease pathology.
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APPENDIX
5.1 Additional Material and Methods: DNA Isolation
DNA was purified according to the manufacturer's instructions using a DNeasy
isolation kit (Qiagen DNeasy). Frozen pellets were thawed and centrifuged for 5 min at
300 x g. Pellets contained lx10 6 cells was for each sample. 150 µL of PBS, 20 µL of
proteinase K, and 200 µL of Buffer AL was added to sample and vortexed thoroughly
followed by incubation in a water bath for 10 min at 56 "C. After incubation, 200 µL of
ethanol was added to each sample and vortexed to yield a homogeneous solution. The
entire mixture was then pipetted into a DNeasy Mini spin column placed in a 2mL
collection tube. Each sample was centrifuged for I min at 6000xg. The flow through and
collection tube was discarded and the DNeasy spin column was placed in new collection
tube. 500ul of Buffer AWi was added to the spin column and centrifuged for 1 min at
6000xg. Flow through and collection tube were discarded and the DNeasy spin column
was placed in new collection tube. 500ul of Buffer AW2 was added to the spin column
and centrifuged for 3 min at 20,000xg to dry the DNeasy membrane. Flow through and
collection tube were discarded and DNeasy spin colmnn was placed in new collection
tube. Sample was centrifuged again for 1 min at 20,000xg to ensure all ethanol was
evaporated from spin column. Flow through and collection tube were discarded and the
DNeasy spin column was placed in a 2ml microcentrifuge tube. lOOul of Buffer AE was
pipetted into the column and centrifuged for 1 min at 6000xg. This step was repeated for
a total of 200ul of eluted DNA in Buffer AE. Samples were frozen and stored at -60°C
until DNA was used for RT-PCR.
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After DNA isolation was performed, overall DNA yield was determined by using
UV Spectrophotometry. Other measurements recorded included purity values:
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5.3 Additional Results
5.3.1 abcX qRT-PCR raw data
AR39
Plate
022415
Plate
031615
Mean
SD

RQvalue at
24 hpi
2.61

RQ value at
48 hpi
1.00

RQ value at
72 hpi
0.47

RQ value at
96 hpi
1.03

RQ value at
120 hpi

3.24

1.00

1.08

0.42

0.63

2.93

1.00

0.78

0.73

NIA

0.45

0.00

0.43

0.43

NIA

RQ value at
24 hpi
1.41

RQvalue at
48 hpi
1.00

RQ value at
72 hpi
0.45

RQvalue at
96 hpi
0.33

RQ value at
120 hpi
0.42

0.78

1.00

3.09

1.07

0.69

1.10

1.00

1.77

0.70

0.56

0.45

0.00

1.87

0.52

0.19

***

Table 3
CWL029
.

Plate
030915
Plate
031615
Mean
SD

..

Table4
Table 3 and 4. Results of abcX gene expression following infection of THP 1 Human
Monocytes with two different Cpn strains AR39 and CWL029. Cells were infected
separately (MOI 1) with Cpn. Cells were lysed and RNA was extracted at 24, 48, 72, 96,
and 120 hpi. 48 hpi was used as a reference time point and J8S was used as a chlamydia!
housekeeping gene to normalize transcription levels. Relative quantity (RQ) refers to the
gene expression level after RT-PCR (Real Time PCR). Individual experiments were
performed with 3 technical replicates. *** represents gene targets that did not amplify
and therefore no RQ values were obtained.
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5.3.2 euo qRT-PCR raw data
·. AR39
.

Plate
021815
Plate
031815
Mean
SD

RQ value at
24 hpi
4.44

RQvalueat
48 hpi
1.00

RQ value at
72 hpi
1.47

RQ value at
96 hpi
0.35

RQ value at
120 hpi
1.35

6.43

1.00

4.73

2.78

2.96

5.44

1.00

3.10

1.57

2.16

1.41

0.00

2.31

1.72

1.14

RQ value at
24 hpi
0.75

RQ value at
48 hpi
1.00

RQ value at
72 hpi
1.08

RQ value at
96 hpi
2.35

RQ value at
120 hpi
2.01

0.74

1.00

***

1.11

0.28

0.75

1.00

NIA

1.73

1.15

0.01

0.00

NIA

0.88

1.22

Table 5
CWL029.
· ..

Plate
031115
Plate
031815
Mean
SD
Table 6

Table 5 and 6. Results of euo gene expression following infection of THP 1 Human
Monocytes with two different Cpn strains AR39 and CWL029. Cells were infected
separately (MOI I) with Cpn. Cells were lysed and RNA was extracted at 24, 48, 72, 96,
and 120 hpi. 48 hpi was used as a reference time point and I BS was used as a chlamydia!
housekeeping gene to normalize transcription levels. Relative quantity (RQ) refers to the
gene expression level after RT-PCR (Real Time PCR). Individual experiments were
performed with 3 technical replicates. *** represents gene targets that did not amplify
and therefore no RQ values were obtained.
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5.3.3 129 qRT-PCR raw data
AR39.

RQ value at
24hpi
1.79

RQ value at
48 hpi
I.DO

RQ value at
72 hpi
1.26

RQ value at
96 hpi
0.19

RQ value at
120 hpi
0.46

Plate
031815
Mean

0.64

1.00

0.9

0.16

***

1.22

1.00

1.08

0.18

NIA

SD

0.81

0.00

0.25

0.02

NIA

RQ value at
24 hpi
0.59

RQ value at
48 hni
I.DO

RQ value at
72 hni
1.21

RQ value at
96hni
1.03

RQ value at
120 hni
0.82

2.19

1.00

***

0.55

0.36

1.39

I.DO

NIA

0.79

0.59

1.13

0.00

NIA

0.34

0.33

..

Plate

Table 7
·cwto29·
..

·

.·

Plate
031115
Plate
031815
Mean
SD
Table 8

Table 7 and 8. Results of 129 gene expression following infection of THP 1 Human
Monocytes with two different Cpn strains AR39 and CWL029. Cells were infected
separately (MOI I) with Cpn. Cells were lysed and RNA was extracted at 24, 48, 72, 96,
and 120 hpi. 48 hpi was used as a reference time point and I BS was used as a chlamydia!
housekeeping gene to normalize transcription levels. Relative quantity (RQ) refers to the
gene expression level after RT-PCR (Real Time PCR). Individual experiments were
performed with 3 technical replicates. *** represents gene targets that did not amplify
and therefore no RQ values were obtained.

